SCHEDULE: North Peak Capital Discloses 5.2% Stake in agilon health
Schedule 13G
North Peak Capital Management and affiliated entities have reported a passive 5.2% beneficial ownership stake in agilon health, Inc. through a Schedule 13G filing.
Summary
- North Peak Capital Management, LLC, along with its affiliated entities and co-managers Jeremy S. Kahan and Michael K. Kahan, has filed a Schedule 13G for agilon health, inc.
- North Peak Capital Management, LLC beneficially owns an aggregate of 21,536,679 shares of agilon health common stock, representing 5.2% of the class.
- North Peak Capital GP, LLC, Jeremy S. Kahan, and Michael K. Kahan each beneficially own 18,276,374 shares, representing 4.4% of the class.
- The beneficial ownership is distributed across several funds: North Peak Capital Partners, LP (1,247,465 shares or 0.30%), North Peak Capital Partners II, LP (10,585,833 shares or 2.6%), North Peak Capital Alpha Fund, LP (5,564,235 shares or 1.3%), and North Peak Capital Ultra Fund, LP (878,841 shares or 0.2%).
- The percentage of class is based on 414,423,149 common shares outstanding as of July 31, 2025, as disclosed in agilon health's Form 10-Q for the quarter ended June 30, 2025.
- The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of agilon health.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of passive beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational or financial news about the issuer.
Positives
- The filing demonstrates transparency regarding significant institutional ownership in agilon health, Inc.
- Compliance with SEC regulations for disclosing beneficial ownership provides clarity to the market.
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by an institutional fund in a healthcare company, agilon health, Inc. Such disclosures are routine for large investors and reflect their portfolio positioning within the healthcare sector.
Stakeholder Impact
- Shareholders of agilon health, inc. are informed of a new significant institutional investor, which may be viewed as a vote of confidence in the company's long-term prospects.
- Potential investors gain transparency into the ownership structure of agilon health, inc.
Key Dates
| Date | Description |
|---|---|
| 2025-07-31 | Date as of which 414,423,149 Common Stock of agilon health, inc. were outstanding, used for percentage calculations. |
| 2025-08-04 | Date agilon health, inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2025. |
| 2025-08-22 | Date of event which required the filing of this Schedule 13G statement. |
| 2025-08-29 | Date the Joint Filing Agreement was executed and the Schedule 13G was signed by all reporting persons. |
Keywords
agilon health, North Peak Capital Management, Schedule 13G, beneficial ownership, institutional investment, common stock, healthcare, investment management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.